ClinicalTrials.gov
public full text
Public Domain
The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain
A pilot study to investigate the potential role of atosiban, a selective oxytocin receptor inhibitor, in the management of endometriosis-related pain. Ten patients will be administered atosiban intravenously during 6 hours on a day during their period when they experience (severe) pain
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The HEROES Trial: Hyperbaric Oxygen Therapy for Endometriosis-Related Pain#892700
- Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling#843661
- Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain#836810
- The Developmental Origins of Endometriosis#892272
- Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?#1088675
Record · ID 1409758
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive